The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 624-630

  Bang, Casper N ^a,b   Greve, Anders M ^a,b   Abdulla, Jawdat ^c   Køber, Lars ^a   Gislason, Gunnar H ^b   Wachtell, Kristian ^a,b  

^a University of Copenhagen   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atrial fibrillation; Inflammation; Meta analysis; Non invasive; Statins

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

CARDIOVERSION; CORONARY ARTERY BYPASS GRAFT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

AF; ATRIAL FIBRILLATION; CABG; CI; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFTING; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INFLAMMATION; META-ANALYSIS; MI; MYOCARDIAL INFARCTION; NON-INVASIVE; PCI; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL/TRIALS; RCT; RELATIVE RISK; RR; STATINS;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RECURRENCE; TREATMENT OUTCOME;

EID: 84880918607     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.08.056     Document Type: Review

References (60)

1. Y. Miyasaka, H. Tsuji, and S. Tokunaga Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation Int J Cardiol 72 2000 229 233
2. W.B. Kannel, R.D. Abbott, D.D. Savage, and P.M. McNamara Epidemiologic features of chronic atrial fibrillation: the Framingham study N Engl J Med 306 1982 1018 1022
3. G. Mariscalco, C. Klersy, and M. Zanobini Atrial fibrillation after isolated coronary surgery affects late survival Circulation 118 2008 1612 1618
4. F. Ravelli Mechano-electric feedback and atrial fibrillation Prog Biophys Mol Biol 82 2003 137 149
5. J. Kalifa, J. Jalife, and A.V. Zaitsev Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation Circulation 108 2003 668 671
6. O. Adam, H.R. Neuberger, M. Bohm, and U. Laufs Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Circulation 118 2008 1285 1293
7. M. Kirstein, M. Rivet-Bastide, S. Hatem, A. Benardeau, J.J. Mercadier, and R. Fischmeister Nitric oxide regulates the calcium current in isolated human atrial myocytes J Clin Invest 95 1995 794 802
8. R.N. Goldstein, K. Ryu, C. Khrestian, D.R. van Wagoner, and A.L. Waldo Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model J Cardiovasc Electrophysiol 19 2008 74 81
9. K. Ryu, L. Li, and C.M. Khrestian Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias Am J Physiol Heart Circ Physiol 293 2007 H1231 H1241
10. T. Liu, L. Li, P. Korantzopoulos, E. Liu, and G. Li Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Int J Cardiol 126 2008 160 170
11. W.T. Chen, G.M. Krishnan, N. Sood, J. Kluger, and C.I. Coleman Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis J Thorac Cardiovasc Surg 140 2010 364 372
12. D.E. Winchester, X. Wen, L. Xie, and A.A. Bavry Evidence of pre-procedural statin therapy a meta-analysis of randomized trials J Am Coll Cardiol 56 2010 1099 1109
13. O.J. Liakopoulos, Y.H. Choi, and E.W. Kuhn Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review J Thorac Cardiovasc Surg 138 2009 678 686
14. L. Fauchier, B. Pierre, L.A. de, C. Grimard, N. Zannad, and D. Babuty Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials J Am Coll Cardiol 51 2008 828 835
15. V. Fuster, L.E. Ryden, and D.S. Cannom ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
16. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
17. J. Dernellis, and M. Panaretou Effect of C-reactive protein reduction on paroxysmal atrial fibrillation Am Heart J 150 2005 1064
18. L.J. Haywood, C.E. Ford, and R.S. Crow Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) J Am Coll Cardiol 54 2009 2023 2031
19. A.S. Adabag, D.B. Nelson, and H.E. Bloomfield Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure Am Heart J 154 2007 1140 1145
20. A.P. Maggioni, G. Fabbri, and D. Lucci Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial Eur Heart J 30 2009 2327 2336
21. Y. Young-Xu, S. Jabbour, and R. Goldberg Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease Am J Cardiol 92 2003 1379 1383
22. G. Ramani, M. Zahid, C.B. Good, A. Macioce, and A.F. Sonel Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome Am J Cardiol 100 2007 404 405
23. A. Kulik, J.P. Singh, R. Levin, J. Avorn, and N.K. Choudhry Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease Am J Cardiol 105 2010 1655 1660
24. C.N. Pellegrini, E. Vittinghoff, F. Lin, S.B. Hulley, and G.M. Marcus Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial Heart 95 2009 704 708
25. M. Ozaydin, Y. Turker, and D. Erdogan The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome Int J Cardiol 141 2010 147 150
26. F. Naji, D. Suran, V. Kanic, D. Vokac, and M. Sabovic Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion Int Heart J 50 2009 153 160
27. C.W. Siu, C.P. Lau, and H.F. Tse Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion Am J Cardiol 92 2003 1343 1345
28. S. Negi, I. Shukrullah, E. Veledar, H.L. Bloom, D.P. Jones, and S.C. Dudley Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial) J Cardiovasc Electrophysiol 22 2011 414 419
29. H. Almroth, N. Hoglund, and K. Boman Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study Eur Heart J 30 2009 827 833
30. M. Ozaydin, E. Varol, and S.M. Aslan Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion Am J Cardiol 97 2006 1490 1493
31. A. Tveit, M. Grundtvig, and T. Gundersen Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion Am J Cardiol 93 2004 780 782
32. P.W. Macfarlane, H. Murray, and N. Sattar The incidence and risk factors for new onset atrial fibrillation in the PROSPER study Europace 13 2011 634 639
33. N. Danchin, L. Fauchier, and E. Marijon Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register Heart 96 2010 1809 1814
34. A. Vedre, H.S. Gurm, and J.B. Froehlich Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol 104 2009 1613 1617
35. Bang CN, Gislason GH, Kober L, Torp-Pedersen C, Wachtell K. Statins Reduce New-Onset AF in a First Time Myocardial Infarction Population - A Nationwide Propensity Score Matched Study. Eur J Prev Cardiol. [Electronic publication ahead of print].
36. G. Amit, A. Katz, and S. Bar-On Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker Clin Cardiol 29 2006 249 252
37. S.P. Bhavnani, C.I. Coleman, and C.M. White Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy Europace 10 2008 854 859
38. C.T. Tsai, L.P. Lai, J.J. Hwang, Y.C. Wang, F.T. Chiang, and J.L. Lin Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial Am Heart J 156 2008 65 70
39. A.M. Gillis, M. Morck, and D.V. Exner Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation Eur Heart J 29 2008 1873 1880
40. T. Komatsu, H. Tachibana, and Y. Sato Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation Int Heart J 50 2009 465 476
41. G.G. Schwartz, B.R. Chaitman, J.J. Goldberger, and M. Messig High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial Am Heart J 161 2011 993 999
42. K.L. Merckx, R.G. Tielman, and R.J. Folkeringa Use of statin is associated with reduced incidence of atrial fibrillation in patients with left ventricular hypertrophy and left atrial dilation Heart Rhythm 1 2003 105 [Suppl.]
43. G.G. Schwartz, A.G. Olson, J. Chaitman, M. Golberger, M. Szarek, and W.J. Saseila Effect of intensive statin treatment on the occurence of atrial aibrillation after acute coronary syndrome: an analysis of the MIRACL trial Circulation 110 2004 740
44. F. Naji, D. Suran, V. Kanic, D. Vokac, and M. Sabovic Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion Med Sci Monit 15 2009 CR494 CR498
45. C.W. Hogue Jr., L.L. Creswell, D.D. Gutterman, and L.A. Fleisher Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 9S 16S
46. J.P. Mathew, M.L. Fontes, and I.C. Tudor A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
47. H. Knotzer, A. Mayr, and H. Ulmer Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study Intensive Care Med 26 2000 908 914
48. Q. Ji, Y. Mei, and X. Wang Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting Circ J 73 2009 2244 2249
49. D. Amar, H. Zhang, P.M. Heerdt, B. Park, M. Fleisher, and H.T. Thaler Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein Chest 128 2005 3421 3427
50. S. Cardin, D. Li, N. Thorin-Trescases, T.K. Leung, E. Thorin, and S. Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and independent pathways Cardiovasc Res 60 2003 315 325
51. S.C. Dudley Jr., N.E. Hoch, and L.A. McCann Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
52. U. Wetzel, A. Boldt, and J. Lauschke Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies Heart 91 2005 166 170
53. M.A. Allessie, P.A. Boyden, and A.J. Camm Pathophysiology and prevention of atrial fibrillation Circulation 103 2001 769 777
54. G.W. Bailey, B.A. Braniff, E.W. Hancock, and K.E. Cohn Relation of left atrial pathology to atrial fibrillation in mitral valvular disease Ann Intern Med 69 1968 13 20
55. K. Rahimi, J. Emberson, and P. McGale Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials BMJ 342 2011 d1250
56. L.E. Moses Measuring effects without randomized trials? Options, problems, challenges Med Care 33 1995 AS8 AS14
57. R. Kunz, and A.D. Oxman The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials BMJ 317 1998 1185 1190
58. K. Benson, and A.J. Hartz A comparison of observational studies and randomized, controlled trials N Engl J Med 342 2000 1878 1886
59. G. Heinze, and P. Juni An overview of the objectives of and the approaches to propensity score analyses Eur Heart J 32 2011 1704 1708
60. E.L. Pritchett Management of atrial fibrillation N Engl J Med 326 1992 1264 1271